As a result, we provide a comprehensive picture of the most important protein-protein interactions within the Bcl-2 family and their alterations in breast cancer or breast cancer subtypes, which can be used as a guide for drug design or cancer target selection. The gene discussed is BCL2; the disease is cancer.